Half-year report · HY
4896.TEDINET S100YW0C
Period2026-01-01 → 2026-06-30
Filed2026-08-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 41
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥471m | 2026-01-01 → 2026-06-30 | Standalone | Operating income |
| Operating income | −¥437m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Ordinary income | −¥485m | 2026-01-01 → 2026-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥921m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥437m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥492m | 2026-01-01 → 2026-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥443m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Net income | −¥493m | 2026-01-01 → 2026-06-30 | Standalone | Profit loss |
| Net income | −¥993m | 2025-01-01 → 2025-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥445m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Total assets | ¥2.6bn | at 2026-06-30 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥1.9bn | at 2025-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2026-06-30 | Standalone | Liabilities |
| Total liabilities | ¥1.7bn | at 2025-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥774m | at 2026-06-30 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2025-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2026-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.8bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.4bn | at 2026-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥526m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥918m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥431m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥40m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥55m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥264,000 | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥138m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-42.4 | 2026-01-01 → 2026-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-85.59 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-38.32 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 30.1% | at 2026-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.1% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.3% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 11,622,600 | at 2026-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,609,600 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,604,600 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Rent expenses sga | InterimDuration_NonConsolidatedMember | 24940000 | JPY |
| Taxes and dues sga | Prior1InterimDuration_NonConsolidatedMember | 8590000 | JPY |
| Taxes and dues sga | InterimDuration_NonConsolidatedMember | 16918000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-08-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第10期中(自 2026年１月１日 至 2026年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ケイファーマ | |
| Company name in english cover page | FilingDateInstant | K Pharma,Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 福島 弘明 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区六本木七丁目７番７号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-6629-3380 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役CFO 松本 真佐人 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区六本木七丁目７番７号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6629-3380 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役CFO 松本 真佐人 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E38985 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48960 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ケイファーマ | |
| Filer name in english | FilingDateInstant | K Pharma, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2026-01-01 | |
| Current period end date | FilingDateInstant | 2026-06-30 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2025-01-01 | |
| Comparative period end date | FilingDateInstant | 2025-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2025-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |